Clinical evaluation reveals efficacy of direct-acting antivirals in HCV-associated cryoglobulinemia and monoclonal gammopathy, indicating dual virologic and hematologic control.
To evaluate the efficacy of direct-acting antivirals (DAA) in patients with hepatitis C virus (HCV) associated cryoglobulinemia and monoclonal gammapathy (MG).
No takes yet. Share an insight, caveat, or question.
Gavrisheva et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: